Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2025

Topics

• The differences in staging between borderline and unresectable locally advanced pancreatic and hepato-biliary cancers
• Identifying patients who will benefit from preoperative therapy prior to surgery
• Identifying patients suitable for a liver transplant
• Identifying patients with resecetable pancreatic cancer who are candidates for a minimally invasive procedure
• Molecular biology of pancreatic and hepato-bilary cancers
• Integrating novel agents in clinical care and clinical trial participation
• Managing neuroendocrine and adeno squamous cell cancers of the pancreas
• The appropriate regimen for first and second line therapy in treating advanced pancreatic cancer and hepato-biliary cancer

Who should Attend

• Gastroenterologists
• Surgeons
• Laboratory scientists
• Medical and radiation oncologists
• Nurse practitioners
• Physician assistants
• Oncology pharmacists
• Registered nurses
• Oncology nurses and clinical research personnel